Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $28.61 USD
Change Today +1.11 / 4.04%
Volume 90.1K
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark J. Gergen J.D.

Chief Operations Officer, Executive Vice President and Secretary, Mirati Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Mark J. Gergen, J.D. has been the Chief Operations Officer and Executive Vice President of Mirati Therapeutics, Inc. since February 19, 2013. Mr. Gergen has been the Chief Operating Officer and Executive Vice President of MethylGene Inc. since February 19, 2013. He serves as Co-Chief Executive Officer of Psylin Neurosciences, Inc. He served as Principal Financial & Accounting Officer and secretary of Mirati Therapeutics, Inc. He served as Senior Vice President of ...

Read Full Background

Corporate Headquarters*

9363 Towne Centre Drive
San Diego, California 92121

United States

Phone: 858-332-3410
Fax: --

Board Members Memberships*

Co-Chief Executive Officer and Director


Minot State University
University Of Minnesota School Of Law

Other Affiliations*

Annual Compensation*

Total Annual Compensation$399,180

Stock Options*

All Other Compensation$2,975
Exercisable Options52,800
Unexercisable Options129,200
Total Number of Options182,000

Total Compensation*

Total Annual Cash Compensation$494,515
Total Short Term Compensation$399,180
Other Long Term Compensation$2,975
Total Calculated Compensation$1,257,343
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRTX:US $28.61 USD +1.11


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIRATI THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at